Dana-Farber Cancer Institute, 450 Brookline Avenue

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Lung Cancer

Studies at this site

• An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer — Completed